Navigation Links
Perrigo to Introduce New Dosing System and Labeling for Certain Pediatric Pain Relievers
Date:5/5/2011

ALLEGAN, Mich., May 5, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced it will be changing the dosing device for pediatric suspensions from a dropper to a new syringe dosing system designed to help consumers more clearly dispense the proper amount of medication. The company will also be labeling its dye-free infants' and children's pediatric suspensions as high-fructose corn syrup-free.

(Photo: http://photos.prnewswire.com/prnh/20110505/DE96260 )

These product improvements will occur this summer when Perrigo and other manufacturers transition to the same single concentration (160 mg / 5 mL) for all single-ingredient over-the-counter (OTC) pediatric liquid acetaminophen products.  At that time, Perrigo's new infant acetaminophen formulas will contain the same amount of active ingredient (per mL) as the current children's pain relief formulas on the market.  Based on a January 2011 survey of 400 practicing pediatricians, Perrigo found that pediatricians support this improvement. Over 80 percent of pediatricians surveyed thought that the active ingredient concentration (per mL) of infant and children's acetaminophen OTC liquid pain reliever/fever reducers should be the same.

A majority of the pediatricians also support the move from a dropper to a syringe dosing system, primarily because they felt the syringe was more accurate, safe and hygienic.  Perrigo will be conducting an extensive pediatrician outreach program to educate pediatricians on the new changes.

Perrigo also recently conducted extensive research with parents on infants' and children's OTC products that relieve pain and reduce fever.  More than half of the 600 mothers surveyed indicated a preference for children's medications that contained no high-fructose corn syrup.  In response, Perrigo will begin labeling their dye-free formulas as "high-fructose corn syrup free."  As part of an earlier, industry-first initiative, all of Perrigo's infant pediatric acetaminophen products will be available with "gluten free" labeling.

"At Perrigo, we pride ourselves in bringing meaningful improvements to market, while continuing to deliver the highest quality and the best value to consumers," said Perrigo's chairman and CEO Joseph C. Papa.

Perrigo is the world's largest manufacturer of over-the-counter (OTC) pharmaceutical products for the store brand market. Today, more than 95 percent of "store brand" – meaning those found under retailers' own brand labels – pediatric acetaminophen and ibuprofen suspensions are manufactured for retailers by Perrigo. The company's infants', children's and adult's ibuprofen and acetaminophen-based pain relievers are manufactured under the same FDA guidelines and contain the same FDA-approved active ingredients as the national brand.  They are available in leading pharmacies and retailers.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the world's largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).


'/>"/>
SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
2. Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Mens Rogaine® Foam
3. Perrigo Company Announces Quarterly Dividend
4. Perrigos PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
5. Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets
6. Perrigo Announces Conclusion of the FDA Re-Inspection
7. Perrigo Company to Present at the Barclays Capital 2011 Global Health Care Conference
8. Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter
9. Perrigo Company to Present at the Citi 2011 Global Health Care Conference
10. Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma
11. Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
Breaking Medicine News(10 mins):